SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Monday reported a loss of $10.5 million in its fourth quarter.The South San Francisco, California-based company said it had a loss of 15 cents per share.The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.The molecular diagnostic company posted revenue of $67.3 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $63.5 million.For the year, the company reported a loss of $75.6 million, or $1.11 per share. Revenue was reported as $219.5 million.Veracyte expects full-year revenue in the range of $260 million to $275 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VCYT at https://www.zacks.com/ap/VCYT